4-127730191-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_031291.4(SLC25A31):c.-355C>G variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.616 in 152,190 control chromosomes in the GnomAD database, including 29,476 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.62 ( 29476 hom., cov: 33)
Consequence
SLC25A31
NM_031291.4 upstream_gene
NM_031291.4 upstream_gene
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -4.40
Publications
2 publications found
Genes affected
SLC25A31 (HGNC:25319): (solute carrier family 25 member 31) The protein encoded by this gene is a member of the ADP/ATP carrier family of proteins that exchange cytosolic ADP for matrix ATP in the mitochondria. Cells over-expressing this gene have been shown to display an anti-apoptotic phenotype. This protein is also thought to play a role in spermatogenesis, where it is believed to associate with a part of the flagellar cytoskeleton and with glycolytic enzymes. Male mice with mutations in the mouse ortholog of this gene are sterile and spermatocytes display an early meiotic arrest phenotype. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.726 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC25A31 | NM_031291.4 | c.-355C>G | upstream_gene_variant | ENST00000281154.6 | NP_112581.1 | |||
| SLC25A31 | NM_001318467.2 | c.-355C>G | upstream_gene_variant | NP_001305396.1 | ||||
| SLC25A31 | XM_011532298.3 | c.-355C>G | upstream_gene_variant | XP_011530600.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.616 AC: 93633AN: 152072Hom.: 29436 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
93633
AN:
152072
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.616 AC: 93726AN: 152190Hom.: 29476 Cov.: 33 AF XY: 0.614 AC XY: 45674AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
93726
AN:
152190
Hom.:
Cov.:
33
AF XY:
AC XY:
45674
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
30425
AN:
41536
American (AMR)
AF:
AC:
9717
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
2074
AN:
3472
East Asian (EAS)
AF:
AC:
2824
AN:
5170
South Asian (SAS)
AF:
AC:
3308
AN:
4832
European-Finnish (FIN)
AF:
AC:
5202
AN:
10590
Middle Eastern (MID)
AF:
AC:
214
AN:
294
European-Non Finnish (NFE)
AF:
AC:
38124
AN:
67978
Other (OTH)
AF:
AC:
1373
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1864
3728
5593
7457
9321
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
782
1564
2346
3128
3910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2242
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.